About BioServe Biotechnologies
BioServe Biotechnologies is a company based in Hyderabad (India) founded in 2002 was acquired by ReproCELL in April 2018. The company has 28 employees as of April 06, 2024. BioServe Biotechnologies operates in a competitive market with competitors including Omniome, Biofidelity, Novogene Corporation, HitGen and Singular Genomics, among others.
- Headquarter Hyderabad, India
- Employees 28 as on 06 Apr, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioserve Biotechnologies (India) Private Limited
- Date of Incorporation 21 Feb, 1994
- Jurisdiction Uppal, Telangana, India
-
Annual Revenue
$757.11 K (USD)26.62as on Mar 31, 2023
-
Net Profit
-$290.7 K (USD)34.77as on Mar 31, 2023
-
EBITDA
-$154.45 K (USD)47.79as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Cancer Genetics
& 1 more
-
Employee Count
28
as on Apr 06, 2024
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BioServe Biotechnologies
Detailed funding history for BioServe Biotechnologies
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in BioServe Biotechnologies
BioServe Biotechnologies has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Cancer Genetics and ReproCELL.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Leading global supplier of iPS-derived cells, stem cell reagents, human biofluids, and 3D cell culture.
|
Locked | Locked | Locked | |
|
Cancer diagnostic solutions are developed for personalized genetic treatments.
|
Locked | Locked | Locked |
Investor details for BioServe Biotechnologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioServe Biotechnologies
Investment portfolio details for BioServe Biotechnologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioServe Biotechnologies
Detailed financials for BioServe Biotechnologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioserve Biotechnologies Comparisons
Peer comparison for BioServe Biotechnologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioServe Biotechnologies
BioServe Biotechnologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, Biofidelity, Novogene Corporation, HitGen and Singular Genomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
Molecular diagnostic assays are developed for target DNA sequence detection.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
DNA-encoded libraries are developed for drug discovery applications.
|
|
| Locked | Locked | Locked |
Next-generation gene sequencing and multi-omics technologies are provided.
|
|
| Locked | Locked | Locked |
Enzymatic DNA synthesis products are provided for researchers.
|
Detailed competitors of BioServe Biotechnologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioserve Biotechnologies
Complete news archive for BioServe Biotechnologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioServe Biotechnologies
BioServe Biotechnologies was founded in 2002.
BioServe Biotechnologies is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
As of Apr 06, 2024, the latest employee count at BioServe Biotechnologies is 28.
Annual revenue of BioServe Biotechnologies is $757.11K as on Mar 31, 2023.
BioServe Biotechnologies was founded in 2002 in Hyderabad, India, within the biotechnology sector. DNA synthesis, sequencing, extraction, and biomarker discovery services are offered to support research and diagnostics. Therapeutics targeting Rett syndrome, Parkinsons disease, glioblastoma, CDKL5 deficiency disorder, and related conditions are developed. Additional services include food pathogen testing and detection of genetically modified organisms in finished products. Molecular biology kits for research purposes are manufactured and supplied.
BioServe Biotechnologies's top competitors include Novogene Corporation, Singular Genomics and Omniome.
BioServe Biotechnologies has 2 investors. Key investors include Cancer Genetics, and ReproCELL.